Lisa Blunt Rochester addresses housing legislation and GOP fiscal policies on social media

Lisa Blunt Rochester U.S. House of Representatives from Delaware%27s at-large district Incumbent - Official U.S. House Headshot
Lisa Blunt Rochester U.S. House of Representatives from Delaware%27s at-large district Incumbent - Official U.S. House Headshot
0Comments

Senator Lisa Blunt Rochester, currently representing Delaware’s at-large district in the U.S. Congress, addressed housing affordability and fiscal policy concerns in a series of posts on July 22 and 23, 2025.

On July 22, Senator Blunt Rochester emphasized the growing difficulty for Americans to find affordable housing. She stated, “It’s no secret: for millions of Americans, a safe, affordable place to call home is drifting further and further out of reach. We need to build more homes– fast. That’s why I’m introducing another bipartisan bill to cut through red tape and help fast-track new homes.” Earlier that day, she also commented simply: “Good ”.

The following day, Blunt Rochester criticized Republican fiscal priorities. On July 23, she wrote, “For years, Republicans called rebuilding roads and bridges, lowering prescription drug costs, and increasing access to food and health care ‘too expensive’. Now, their massive billionaire handout is going to make our debt and deficit even WORSE. Cost was never the problem.”

Blunt Rochester has represented Delaware since 2017 after succeeding John Carney. Born in Philadelphia in 1962 and currently residing in Wilmington, she holds a BA from Fairleigh Dickinson University (source: Lisa Blunt Rochester biography).



Related

Sridhar Mantha, Acting Chief Information Officer of FDA

How many companies were inspected by the FDA in cities located in New Castle County in 2025?

There were 22 companies in cities associated with New Castle County that received 22 FDA inspections in 2025, according to the U.S. Food and Drug Administration.

Jim Traficant, Chief of Staff of FDA

FDA inspects Accugenix, LLC in Newark on April 22 for drug quality controls

The Food and Drug Administration inspected Accugenix, LLC in Newark on April 22 to review drug quality control measures, as shown in data released on the FDA’s website.

Dr. Mehmet Oz CMS Administrator

Medicaid dental service payments in Newark climb 2.4% in 2024

Medicaid payments for Dental Services in Newark increased by 2.4% in 2024, indicating adjustments in usage and reimbursement patterns.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from North New Castle News.